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Abstract 
Background: Next‑generation sequencing allows for determining the genetic composition of a mixed sample. For 
instance, when performing resistance testing for BCR‑ABL1 it is necessary to identify clones and define compound 
mutations; together with an exact quantification this may complement diagnosis and therapy decisions with addi‑
tional information. Moreover, that applies not only to oncological issues but also determination of viral, bacterial or 
fungal infection. The efforts to retrieve multiple haplotypes (more than two) and proportion information from data 
with conventional software are difficult, cumbersome and demand multiple manual steps.
Results: Therefore, we developed a tool called cFinder that is capable of automatic detection of haplotypes and 
their accurate quantification within one sample. BCR‑ABL1 samples containing multiple clones were used for test‑
ing and our cFinder could identify all previously found clones together with their abundance and even refine some 
results. Additionally, reads were simulated using GemSIM with multiple haplotypes, the detection was very close to 
linear (R2 = 0.96). Our aim is not to deduce haploblocks over statistics, but to characterize one sample’s composition 
precisely. As a result the cFinder reports the connections of variants (haplotypes) with their readcount and relative 
occurrence (percentage). Download is available at http://sourceforge.net/projects/cfinder/.
Conclusions: Our cFinder is implemented in an efficient algorithm that can be run on a low‑performance desktop 
computer. Furthermore, it considers paired‑end information (if available) and is generally open for any current next‑
generation sequencing technology and alignment strategy. To our knowledge, this is the first software that enables 
researchers without extensive bioinformatic support to designate multiple haplotypes and how they constitute to a 
sample.
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Background
The onset of next-generation sequencing (NGS) plat-
forms in many laboratories enables researchers to 
quantify the genetic composition of a specific sample. 
Assuming that each cell of this sample produces the same 
amount of DNA a relative quantification can be deduced 
from the overall amount of sequencing reads [1].
454 sequencing allows for long reads up to 1000  bp, 
reading through most target regions where phasing 
is necessary. 454’s pyrosequencing strategy reads one 
template DNA molecule in either forward or reverse 
direction [2]. Illumina can also do paired end sequencing, 
where every DNA fragment is read in both directions and 
can be matched, even if there is no overlap. It is evident 
that both technologies allow for the detection of haplo-
types although different sequencing strategies must be 
applied.
However, the detection of compound mutations as in 
BCR-ABL1 for resistance testing and the quantification 
of the found clones have to be performed manually [3]. 
This process is not just time-consuming but also error 
prone. To our knowledge there is no software yet that 
can effectively detect and exactly quantify multiple 
haplotypes without extensive bioinformatics assistance. 
Open Access
*Correspondence:  norbert.niklas@o.roteskreuz.at 
1 Red Cross Transfusion Service for Upper Austria, Krankenhausstraße 7, 
4017 Linz, Austria
Full list of author information is available at the end of the article
Page 2 of 6Niklas et al. BMC Res Notes  (2015) 8:422 
There are some tools (e.g. HaplotypeCaller of GATK) 
that can establish phasing but these tools provide no 
ability to detect more than two clones or calculate 
quantities. GS Amplicon Variant Analyzer (AVA, 454 
Life Sciences, Branford, CT) is the only software that 
allows the definition of combined variants manually, 
with additional manual calculation steps. CLCbio’s 
Genomics Workbench 7.0 (GWB, CLCbio, Aarhus, 
Denmark) is able to link mutations in the same coding 
triplet only.
Ultra-deep sequencing with a coverage of multiple 10 k 
reads per target is necessary to yield accurate quantities 
[4]. Because exact phasing of whole genome or whole 
exome data is impossible and approximation just fea-
sible statistically [5], we assume a rather small size (up 
to 10 k bp) as a region of interest in the human genome 
(trade-off between region size and coverage) [6].
cFinder is capable of analysing sequence data inde-
pendent of any sequencing platform, organism and 
library preparation strategy. Prerequisites are a reference 
sequence and a medical or biological expert. Moreover, 
a graphical user interface provides convenient usage, so 
that our tool can be applied without bioinformatics or 
scripting knowledge. Our aim is not to sequence multi-
ple samples and to deduce haploblocks (multiple variants 
passed on together by meiosis) over statistical occur-
rences in a population, but to characterize one sample 
and its composition precisely.
Technicalities
The software can be run on any desktop computer with.
NET 4.0 installed, memory usage and runtime are both 
reduced to a minimum. Assuring the highest degree of 
flexibility, no mapping or alignment algorithm is directly 
implemented (see Additional file 1).
Thus, the software is able to work with the most com-
mon mapping formats ACE and SAM (unpadded and 
padded) [7]. An annotation file (genebank format *.gb 
or user defined) allows the calculation of amino acid and 
coding sequence changes.
The architecture of the software allows for loading an 
enormous amount of reads (coverage), just affecting load-
ing time. For 4  M simulated reads in paired end mode, 
cFinder consumed 811 MB memory and took 11.2 min to 
load the data, calculation was done in 11 s; for 8 M simu-
lated reads loading took 23.8  min and calculation 22  s; 
conducted with 2.67 GHz and 6 GB RAM.
The output of the software is a list of connected vari-
ants (haplotypes) occurring with the same pattern on 
multiple reads. Additionally the coding region change 
and the amino acid change are reported. Hence, it can 
be investigated what variants occur together. The abso-
lute number of reads with this variant combination is 
displayed together with the calculated percentage. This 
information may be exported in csv or MS Excel format.
Usage and workflow
All tasks after the initial loading step run in linear time 
(target region size or coverage), the workflow is summa-
rized in Fig. 1.
The software parses the mapping file and associates 
found haplotypes per read. At this step all variations 
(including sequencing errors) are used to create the hap-
lotypes. Consecutive variants following each other are 
reported in a combined and single format, likewise are 
variants in one coding triplet.
Found variants are displayed and filtering is feasible. 
Subsequently, the user may select relevant variants. These 
can be designated for a specific genus of bacteria or vari-
ants that are responsible for resistance against medica-
tion [8], e.g. variant definitions from COSMIC database 
can be loaded.
The previously stored haplotypes are recalculated 
based on the selected variants and reported together with 
their percentage. Haplotypes as well as variants can be 
exported; hence, monitoring a patient at different time 
points is possible.
Methods



























Fig. 1 Workflow for using cFinder. Sequencing data is aligned against 
a reference sequence by a user defined tool (blue) and result is loaded 
in sam or ace format (together with optional annotation information) 
into cFinder, where variant detection is accomplished and optional 
filtering can be performed. After selection of desired variants clones 
are automatically calculated and presented for further evaluation
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the number of reads with this haplotype’s variant compo-
sition divided by the coverage at these positions. Cover-
age might vary over the reference sequence. Reads not 
covering the variant positions will be counted as wild 
type (wt), hence the sum of all percentages will not sum 




Only sequence reads exactly matching the variants of 
the assigned haplotype are counted. There is no further 
statistics applied to the found haplotypes, only the extrac-
tion of all occurrences in a highly efficient way. Forward 
and reverse fragments of paired-end reads (if available) 
are connected to establish a haplotype. Ambiguous bases 
in a paired-end overlap are not counted as a variant (by 
definition one of them is a sequencing error).
Overlapping amplicons
Specialized amplicon designs have to be developed when 
read length is shorter than region of interest (see Fig. 2). 
If this is not uniformly covered by design, the ampli-
con positions must be loaded (to perform correct cal-
culations). For these amplicon designs the user finds a 
specialized checkbox “Infer Relationship(s)” where haplo-
types scattered over multiple amplicons are again recon-
nected. The algorithm creates a symmetric, unweighted 
graph with nodes representing variants and edges repre-
senting an occurrence on (at least) one sequence. In this 
graph, the largest subgraph is determined where all nodes 
are connected with all other nodes in the subgraph (find-
ing this graph is referred to as maximum clique problem 
in graph theory). The subgraph defines a new haplotype, 
and readcounts for contributing fragments are recalcu-
lated. Fragments and connections with no reads left are 
removed and the next largest subgraph is searched. Since 
the maximum clique problem is NP-complete [9], this is 
the only computationally expensive task after loading. It 
is limited to 15 rounds and 20 variants to be accomplisha-
ble on a desktop computer. The output for an overlapping 
amplicon design does not differ from the above described 
output. Concerning the connections between variants, 
some might be detected that cannot be found on reads. It 
should be noticed that this combinatorial task is complex 
and sophisticated and there are cases where no connec-
tion can be achieved at all, especially with high number 
of variants and overlapping subgraphs.
Results and discussion
Next-generation sequencing data generated from long-
range BCR-ABL1 sequencing was utilized for evaluation 
and testing [8]. The original data consist of sequencing 
one 933 bp amplicon for eleven samples with 29 clones 
detected by manual investigation (using 454 GS FLX+ 
technology, AVA, CLC GWB and manual calculation of 
clones and percentages), ten samples were used for sub-
sequent analysis  (see also Additional file  2). Approval 
of an ethics committee is not required for this analy-
sis. Alignments of individual reads from AVA and CLC 
GWB using the Large Gap Mapper tool (settings m2, i3, 
d1, s0.7, l0.7) were loaded and annotated in our cFinder, 
and both compared to previous (manual) results from 
[8]. Clinically relevant variants were selected and clone 
detection yielded 38 clones in 10 samples. All previously 
detected clones could be confirmed and clones with 
a percentage greater or equal to 1  % were investigated. 
Correlations of clones’ percentages with manual data 
were 0.973 for AVA as well as for CLC alignments and 
correlations of counted number of reads were 0.995 and 
0.993 for AVA and CLC, respectively.
Since alignment of a large 540 bp deletion (well-known 
for the BCR-ABL fusion product) in sample 8 is not pos-
sible by AVA, it was just analyzed with the alignment 
created by CLC. All clones with a percentage greater or 
equal to 1 % were investigated.
A detailed comparison is presented in detail in Table 1. 
For four samples more clones were detected, represent-
ing sub clones of the manually defined ones. In one of 
them, this leads to reduced percentages of previously 
reported clones. Just five clones differed by more than 
10 percentage points, although a similar number of reads 
was reported (different calculation).
Two clones fell below the 1 % limit with the improved 
calculation and would not be treated as real clones. The 
results generated with AVA and CLC differ for one clone 
only.
Deviation from manual results is evident due to differ-
ent definition of compound mutations and calculation 
(n = 2numVariants possible combinations, where num-
Variants is the number of variants of interest). Manual 
calculation did not take coverage at variant position 
into account, while AVA does not output the number of 
reads concerning sub clones accurately. Our software 
tool detects occurring haplotypes automatically, count-
ing each read just once and calculates the frequencies 
adjusted to the coverage at the variants position.
region of interest
Fig. 2 Overlapping multi‑amplicon paired‑end design. Schematic 
representation of covering a region larger than the maximum read‑
ing length, haplotypes are therefore scattered in multiple sequence 
reads. Reference sequence is displayed in black, amplicons in forward 
(green) and reverse (red), pairs (but not covered regions) are denoted 
with a dashed line
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No real data were available for a multi-amplicon design, 
therefore two artificial alignments were created (Fig. 3). 
Our software managed to infer the haplotypes scattered 
over multiple amplicons and extract their correct clones 
and counts (Table 2).
Besides, we used GemSIM to simulate 100  k reads 
(l = 600) for a short (924 bp) fragment of E. coli using the 
profile for 454 data [10]. In total 26 test cases had 133 dif-
ferent haplotypes (min. 3, max. 8 haplotypes with each up 
to 9 variants, avg. 4.2 variants). We included multiple clones 
(haplotypes) that were created by the GemSIM software 
(GemHaps.py) along with sequencing errors. After align-
ment with CLC GWB the cFinder detected all haplotypes. 
Using the absolute number of reads detected the estimated 
percentages correlated with R2 = 0.96 that is nearly linear. 
The deviation can be related to the high number of errors 
included in the 454 profile. Figure 4 displays a scatterplot 
visualizing the simulated and detected percentages.
Table 1 Comparison of alignment methods and cFinder to manual approach
Sample and found clone variants are listed with their percentage of occurrence and the hits (absolute number of reads with that variant), comparing manual 
detection with automated analysis with cFinder with two different alignment software products. Results marked with one star (*) show intense deviation from manual 
findings, numbers marked with two stars (**) fell below threshold of 1 %. If clone was not detected it is marked with a dash (–)
Sample (no.) Clone variants Manual cFinder (AVA) cFinder (CLCbio)
% Hits % Hits % Hits
1 c.749 G>A 22.0 14,956 23.3 15,611 22.43 14,745
c.757 T>C 26.5 18,458 30.6 20,886 29.39 19,604
2 c.749G>A, c.943A>G, c.1497A>G 15.7 4748 6.4 4362 6.21 4066
c.749G>A, c.949T>A, c.1497A>G 4.1 1240 2.4 1641 2.3 1522
c.749G>A, c.1497A>G 22.7 6864 7.1* 4145 6.7* 3729
c.943A>G, c.1497A>G 17.1 16,237 12.6 9183 12.5 8715
c. 949T>A, c.1497A>G 3.3 3128 4.5 3342 4.6 3240
c.1497A>G 45.2 26,522 61.2* 35,867* 61.3* 33,804
c.749G>A, c.949T>A – – 3.4 2519 3.5 2488
c.749G>A – – 13.9 7996 14.2 8074
c.749G>A, c.943A>G – – 10.8 7838 10.9 7692
c.943A>G – – 4.0 3483 4.2 3574
c.949T>A – – 1.1 991 1.2 1023
3 c.1375G>A, c.1423_1424ins35 6.2 3495 5.9 3186 6.4 3019
c.1375G>A 90.9 51,247 90.9 51,891 87.9 42,693*
4 c.730A>G 20.3 9887 27.5 17,769 27.5 17,483*
5 c.756G>T, c.1086_1270del185 5.4 1407 6.2 1406 6.8 1490
c.756G>T, c.1423_1424ins35 1.0 160 1.6 244 0.2** 30
c.756G>T 41.0 10,845 58.9* 12,446* 57.3* 11,545
c.1423_1424ins35 – – 1.6 244 1.6 235
c.1086_1270del185 2.7 727 2.6 625 2.6 611
c.888_919del32 1.6 427 0.9** 220 0.2** 40
6 c.756G>>T, c.1086_1270del185 20.4 8151 14.1 7922 14.1 7702
c.1086_1270del185 – – 6.3 4008 4.6 2828
c.756G>T 64.6 32,472 65.0 31,932 63.3 30,093
7 c.756G>T 51.2 38,883 62.3* 38,726 61.5* 37,336
8 c.838_1378del540, c.1423_1424ins35 98.4 49,425 – – 85.7* 47,729
c.1423_1424ins35 – – – – 2.1 1187
c.838_1378del540 – – – – 10.8 6013
9 c.825G>A 2.2 229 3.1 269 3.0 250
10 c.1086_1270del185, c.1423_1424ins35 1.3 278 0.5** 132 0.5** 116
c.944C>T, c.1086_1270del185 9.1 2260 7.5 2215 5.3 1548
c.944C>T 30.6 9778 33.7 10,069 34.3 10,061
c.1086_1270del185 12.1 3278 10.4 3026 7.4 2164
c.1423_1424ins35 2.1 460 1.9 384 1.8 375
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Conclusion
cFinder is easy to use and quickly identifies and 
quantifies clones in a mixed sequencing result this 
discriminates the cFinder from other software products. 
Overall, all clones and their frequencies are designated 
with a minimum of user interaction. The tool can be 
used for data analysis for research as published in [8]. 
Both alignment types (AVA and CLC) showed a similar 
performance, supported the previous manual findings, 
and could even refine them in some cases. The simula-
tion experiment confirms the high accuracy. Thus, our 
cFinder is completely independent from any alignment 
tool or settings, allowing for a maximum of flexibility for 
a specific application.
wt, n = 4
2 mut, n = 2
3 mut, n = 1
1 mut, n = 5
3 mut, n = 3
4 mut, n = 1
wt, n = 1
















Fig. 3 Test scenarios for overlapping amplicon design. Two test scenarios were created with simulated reads, consisting of three clones (a) and five 
clones (b). Each line represents a clone having different variants (numbered squares), scattered over multiple sections of amplicon design (see Fig. 2)
Table 2 Test of simulated data with overlapping amplicons
Comparison of using the infer relationship option to detect haplotypes that 
are scattered over multiple amplicons. The column clone variants holds a list 
of variants (numbered according to Fig. 3, design of the test cases) where “1, 
3” means that the clone has variant 1 and variant 3. Default analysis yields 
just occurring haplotypes on simple amplicons while ticking the checkbox for 
inferring haplotypes manages to identify the connected variants. If clone was 
not detected it is marked with a dash (–), true haplotypes (used for simulation) 
are marked with a star (*)
Test Clone variants Default Infer relation-
ships
% Hits % Hits
A 1 23.8 5 – –
3 23.8 5 – –
1, 3* 14.3 3 28.6 2
1, 2 4.8 1 – –
2 4.8 1 – –
2, 3 4.8 1 – –
1, 2, 3* – – 14.3 1
B 3* 43.8 21 37.5 6
2* 37.5 18 31.3 5
2, 3 8.3 4 – –
3, 4 8.3 4 – –
2, 4 8.3 4 – –
4 6.3 3 – –
1, 4 2.1 1 – –
1, 3 2.1 1 – –
1, 2 2.1 1 – –
2, 3, 4* – – 18.8 3


























Fig. 4 Scatterplot of simulated reads. The frequencies of clones were 
plotted against the actual detected frequencies. One dot represents 
one clone, perfect matches are on the red line
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Availability and requirements
  • Project name: cFinder.
  • Availability (including test data): http://sourceforge.
net/projects/cfinder/.
  • Operating system(s): Windows.
  • Programming language: C#.
  • Other requirements: .NET 4.0 or higher.
  • License: GNU GPL v3.0
  • Any restrictions for commercial usage: license 
needed.
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bench; COSMIC: catalogue of somatic mutations in cancer; SAM: sequence 
alignment/map format.
Authors’ contributions
NN implemented part of the software, performed analysis and wrote the 
manuscript. JH wrote source code and performed tests. AB and KW performed 
manual analysis and critically reviewed the manuscript. SD significantly con‑
tributed to the infer relationships algorithm. JP and CG designed the concept 
and critically reviewed the manuscript. TL and SP contributed to the testing 
phase. PV contributed to the concept of the algorithm. All authors read and 
approved the final manuscript.
Author details
1 Red Cross Transfusion Service for Upper Austria, Krankenhausstraße 7, 
4017 Linz, Austria. 2 University of Applied Sciences Upper Austria, Softwarepark 
11, 4232 Hagenberg, Austria. 3 Children’s Cancer Research Institute, Vienna, 
Austria. 4 Division of Hematology and Hemostaseology, Department of Medi‑
cine I, Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, 
Vienna, Austria. 
Additional files
Additional file 1: Archive containing the cFinder software. Includes 
executable, library and settings files.
Additional file 2: Archive containing test data. Include annotations 
and exemplary alignment files from AVA and CLC for sample 5, as well as 
simulated test reads for overlapping amplicons.
Acknowledgements
This work was supported by the Austrian Science Fund (FWF), SFB Grants 
F4704‑B20 and F4705‑B20.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 11 July 2014   Accepted: 24 August 2015
References
 1. Ladetto M, Bruggemann M, Monitillo L, Ferrero S, Pepin F, Drandi D et al. 
Next‑generation sequencing and real‑time quantitative PCR for minimal 
residual disease detection in B‑cell disorders. Leukemia. 2013;28(6):1299–307.
 2. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, et al. 
Genome sequencing in microfabricated high‑density picolitre reactors. 
Nature. 2005;437:376–80.
 3. Khorashad JS, Kelley TW, Szankasi P, Mason CC, Soverini S, Adrian LT, et al. 
BCR‑ABL1 compound mutations in tyrosine kinase inhibitor‑resistant 
CML: frequency and clonal relationships. Blood. 2013;121:489–98.
 4. Beerenwinkel N, Zagordi O. Ultra‑deep sequencing for the analysis of viral 
populations. Curr Opin Virol. 2011;1:413–8.
 5. Kuleshov V, Xie D, Chen R, Pushkarev D, Ma Z, Blauwkamp T et al. Whole‑
genome haplotyping using long reads and statistical methods. Nat 
Biotechnol. 2014;32(3):261–6.
 6. Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP. Sequencing depth 
and coverage: key considerations in genomic analyses. Nat Rev Genet. 
2014;15:121–32.
 7. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The 
sequence alignment/map format and SAMtools. Bioinformatics. 
2009;25:2078–9.
 8. Kastner R, Zopf A, Preuner S, Proll J, Niklas N, Foskett P, et al. Rapid iden‑
tification of compound mutations in patients with Philadelphia‑positive 
leukaemias by long‑range next generation sequencing. Eur J Cancer. 
2014;50:793–800.
 9. Randy C, Panos MP. An exact algorithm for the maximum clique problem. 
Oper Res Lett. 1990;9:375–82.
 10. McElroy KE, Luciani F, Thomas T. GemSIM: general, error‑model based 
simulator of next‑generation sequencing data. BMC Genom. 2012;13:74.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
